
|Articles|November 10, 2012
Preclinical study suggests no harm to limbal stem cells from CXL
Preliminary results of a preclinical study investigating the effect of peripheral collagen crosslinking on the limbal stem cells provide some reassurance about the safety of the technique.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
2
Sunir Garg, MD, FACS, previews retina highlights at AAO 2026
3
EURETINA 2026: Eyestem interim Phase 2 results for clinical study of Eyecyte-RPE for GA secondary to dry AMD
4
EURETINA 2026: Duravyu misses LUGANO endpoint but cuts treatment burden by 42%
5














